×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [58]
内容类型
期刊论文 [58]
发表日期
2022 [17]
2021 [18]
2020 [9]
2019 [3]
2018 [3]
2017 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共58条,第1-10条
帮助
限定条件
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Guo-Zhen
;
Ma, Li-Ying
;
Zhang, Zong-Hui
;
Wang, Xiao-Lin
;
Hua, Jing-Han
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/22
small-cell lung cancer
H3
3
PARP1
PARP inhibitor
darinaparsin
combination treatment
Protein disulfide isomerase blocks the interaction of LC3II-PHB2 and promotes mTOR signaling to regulate autophagy and radio/chemo-sensitivity
期刊论文
CELL DEATH & DISEASE, 2022, 卷号: 13
作者:
Wang, Ruru
;
Shang, Yajing
;
Chen, Bin
;
Xu, Feng
;
Zhang, Jie
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2022/12/22
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:
Wu, Xiaofan
;
Yang, Hongjian
;
Yu, Xingfei
;
Qin, Jiang-Jiang
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/22
HER2
breast cancer
targeted therapy
drug resistance
overcoming strategies
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer
期刊论文
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 卷号: 21
作者:
Chen, Keyu
;
Wu, Jiayi
;
Fang, Ziru
;
Shao, Xiying
;
Wang, Xiaojia
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/12/22
early-stage breast cancer
genomic expression profiles
Oncotype DX
MammaPrint
RecurIndex
prediction tools
Injectable magnetic montmorillonite colloidal gel for the postoperative treatment of hepatocellular carcinoma
期刊论文
JOURNAL OF NANOBIOTECHNOLOGY, 2022, 卷号: 20
作者:
Chen, Sheng
;
Song, Yonghong
;
Yan, Xu
;
Dong, Liang
;
Xu, Yunjun
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2022/12/23
Colloidal gel
Magnetic hyperthermia
Hepatocellular carcinoma
Postoperative therapy
Hemostasis
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
期刊论文
MOLECULAR CANCER, 2022, 卷号: 21
作者:
Zhu, Chunxiao
;
Guan, Xiaoqing
;
Zhang, Xinuo
;
Luan, Xin
;
Song, Zhengbo
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
KRAS mutations
Druggable
Resistance
Combination therapy
Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11
作者:
Zhang, Yanqiang
;
Xu, Xiaoqing
;
Hu, Can
;
Du, Yian
;
Ding, Guangyu
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/23
Gastric cancer
HER2-positive
conversion therapy
©版权所有 ©2017 CSpace - Powered by
CSpace